Unlike its two main, yet smaller, competitors Sinopharm is a pure-play medical distributor that does not have a sizable portion of revenue from the manufacturing business. As the largest medical ...

A fourth shot of the COVID-19 Sinopharm vaccine will not provide any additional protection against the disease, according to a study from the Sun Yat-sen University in Guangzhou released earlier ...

The state-backed firm known as Sinopharm, which holds a controlling stake in China TCM, is talking with advisers about a new offer to potentially take the company private, the sources said ...

Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener The latest ...

10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Sinopharm Group Co Ltd., together with its subsidiaries, engages in the ...

KUALA LUMPUR: Duopharma Biotech Bhd ’s unit is distributing the Sinopharm Covid-19 vaccine following the arrival of a shipment as the company contributes to the vaccination efforts in Malaysia.

The Minister also explained the new phase will encompass people over 50 years of age who have already received two shots of Sinopharm's drug as well as all those immunosuppressed over 3 years of age.

Morocco is already producing the Chinese Sinopharm vaccine, with more than three million doses being made per month. By next month it plans on producing five million doses and more than 20 million ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

ET Net News Agency, 28 February 2025] 2 listed companies see active trades and price swing at 9:52am Listed companies Price Change(%) Status ------------------------------------- ...